RecruitingPhase 4

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

South Korea76 participantsStarted 2023-12-01

Plain-language summary

The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine

Who can participate

Age range4 Years – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3. Exclusion Criteria: * ASA classification 3 or more * impaired liver function * impaired kidney function * myasthenia gravis or other neuromuscular disorders * history of drug allergy * cardiovascular disease or arrhythmia

What they're measuring

The incidence of EA in postanesthesia care unit (PACU)

Timeframe: EA is assessed three times at 15-minute intervals in PACU until discharge from PACU.

Trial details

NCT IDNCT06035757

SponsorKonkuk University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-30

Contact for this trial

Yea-Ji Lee, M.D Ph. D

+82-2-2030-5450 ladydaisy82@naver.com

View on ClinicalTrials.gov More Emergence Delirium trials